Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

The FDA has approved an application by Merck (MRK +0.7%) to switch the status of the...

  • Friday, January 25, 2:56 PM ET
    The FDA has approved an application by Merck (MRK +0.7%) to switch the status of the prescription patch Oxytrol, a treatment for overactive-bladder, to an over-the-counter item for women. The OTC patch, which will remain a prescription-only product for men, will be available this fall.
Track new comments on this story

This news story has 1 comment:

  •  
    Wait a minute! If it's OTC why can't men buy it?
    25 Jan, 05:25 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »